Hypoproteic Diet in Acromegaly

Launched by AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITA · Mar 18, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how a low-protein diet might help people with acromegaly, a condition caused by too much growth hormone in the body. Researchers believe that reducing protein intake could lower the levels of growth hormone and insulin-like growth factor 1 (IGF-I) in patients who are already receiving standard treatments. The study will also examine how this diet affects the body's metabolism and gut bacteria during treatment.

To participate in the trial, individuals must be between 18 and 65 years old, have a diagnosis of acromegaly, and be currently treated with a type of medication called somatostatin analogues. Unfortunately, the study cannot include pregnant or breastfeeding individuals, those with substance abuse issues, cancer, or blood disorders. Participants will be closely monitored and can expect to follow a specific diet while contributing to valuable research that could improve treatment for acromegaly in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18/65
• • Diagnosis of Acromegaly
• • In therapy with somatostatin analogues
• Exclusion Criteria:
• • pregnancy or lactation
• • alchool or drugs abuse
• • cancer
• • Hematological diseases